Importance of Patient-Centered Outcomes When Evaluating Treatments for Secondary Progressive Multiple Sclerosis.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32105183.
- Also identified by DOI 10.18553/jmcp.2020.26.3.239 and PMC identifier 10391106.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
No funding supported the writing of this commentary. The author has nothing to disclose.
Medical subject headings
- Multiple Sclerosis, Chronic Progressive
- Patient Reported Outcome Measures